Taichu Biotechnology Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 17

Taichu Biotechnology General Information

Description

Operator and developer of a biopharmaceutical company intended to become a CRO+CDMO technology platform for the whole industry chain. The company's business focus is from drug non-clinical research to CDMO, its services include non-clinical drugability evaluation (CRO) of biomedicine, antibody drug development and production (CRO/CDMO), research and development of chemical preparations, and CDMO services, providing tailor-made CRO+CDMO technical services for single and combined business segments for the R&D and production of various new drugs.

Contact Information

Website
taichubio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 6, No. 308, Pingda Road, Lingang New Area
  • Fengxian District
  • Shanghai, 200000
  • China
+86 021
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Building 6, No. 308, Pingda Road, Lingang New Area
  • Fengxian District
  • Shanghai, 200000
  • China
+86 021

Taichu Biotechnology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Taichu Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A1) 08-Mar-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 08-May-2023 Completed Generating Revenue
2. Early Stage VC 15-Aug-2022 $44.7M Completed Generating Revenue
1. Early Stage VC 18-Jul-2022 $44.7M $44.7M Completed Generating Revenue
To view Taichu Biotechnology’s complete valuation and funding history, request access »

Taichu Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator and developer of a biopharmaceutical company intended to become a CRO+CDMO technology platform for the whole in
Biotechnology
Shanghai, China

Shanghai, China
 

Shanghai, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Taichu Biotechnology Competitors (2)

One of Taichu Biotechnology’s 2 competitors is Shanghai Medicilon, a Formerly VC-backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shanghai Medicilon Formerly VC-backed Shanghai, China
ChemPartner Formerly PE-Backed Shanghai, China
You’re viewing 2 of 2 competitors. Get the full list »

Taichu Biotechnology Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fortera Capital PE/Buyout Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Shanghai Guanyu Investment Development Growth/Expansion Minority
TigerYeah Capital Venture Capital Minority
Ao Peng Investment PE/Buyout Minority
You’re viewing 5 of 17 investors. Get the full list »

Taichu Biotechnology Acquisitions (1)

Taichu Biotechnology’s most recent deal was a Merger/Acquisition with Taijin Biotechnology. The deal was made on 27-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Taijin Biotechnology 27-Jan-2022 Merger/Acquisition Biotechnology
To view Taichu Biotechnology’s complete acquisitions history, request access »

Taichu Biotechnology Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Taijin Biotechnology Shanghai, China 2021

Taichu Biotechnology FAQs

  • When was Taichu Biotechnology founded?

    Taichu Biotechnology was founded in 2020.

  • Where is Taichu Biotechnology headquartered?

    Taichu Biotechnology is headquartered in Shanghai, China.

  • What industry is Taichu Biotechnology in?

    Taichu Biotechnology’s primary industry is Biotechnology.

  • Is Taichu Biotechnology a private or public company?

    Taichu Biotechnology is a Private company.

  • What is Taichu Biotechnology’s current revenue?

    The current revenue for Taichu Biotechnology is .

  • How much funding has Taichu Biotechnology raised over time?

    Taichu Biotechnology has raised $103M.

  • Who are Taichu Biotechnology’s investors?

    Fortera Capital, Hangzhou Tailong Venture Capital Partnership, Shanghai Guanyu Investment Development, TigerYeah Capital, and Ao Peng Investment are 5 of 17 investors who have invested in Taichu Biotechnology.

  • Who are Taichu Biotechnology’s competitors?

    Shanghai Medicilon and ChemPartner are competitors of Taichu Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process